St. Louis Business Journal – Bayer has agreed to pay $1.6 billion to settle about 90% of the 39,000 legal claims in the U.S. over injuries women said were related to their use of the German pharmaceuticals company’s Essure birth control device.
The settlements include all of the jurisdictions with significant volumes of Essure cases. It also includes an allowance for outstanding claims.
The company said in announcing the settlement:
“With the settlements, Bayer resolves virtually all of the U.S. Essure litigation so that the company can focus on its commitment to women’s health, where it has long been a leader, without the distractions and uncertainties associated with this litigation.
“There is no admission of wrongdoing or liability by Bayer in the settlement agreements.”
Bayer said in 2018 that it would end sales of the birth control product in the U.S., citing declining sales of the implantable device and not based on safety concerns … Read more.